INVO Fertility (IVF) Stock Price, News & Analysis

Company Overview

NAYA Biosciences (NASDAQ: NAYA) is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility. Our hub & spoke model harnesses the shared resources of a parent company and agility of lean strategic franchises, enabling efficient acquisition, development, and partnering of assets as well as optimized return on investment by combining the upside of innovative clinical-stage therapeutics with scalable, profitable commercial revenues. NAYA’s expanding portfolio of assets currently includes NY-303, a GPC3 and NKp46 targeting bispecific antibody for the treatment of hepatocellular carcinoma (HCC) with a unique mode of action targeting non-responders to the current immunotherapy standard of care (approximately 70% of the current treatable market) cleared to enroll patients in a Phase I/II monotherapy trial in early 2025, NY-338, a CD38 and NKp46 targeting bispecific antibody for the treatment of multiple myeloma and autoimmune diseases with a differentiated safety and efficacy profile, and INVOcell®, an FDA-approved fertility device which has demonstrated comparable success rates to traditional In Vitro Fertilization (IVF).

Key Stats

• Today's Range: $1.42 to $1.48
• 50-Day Range: N/A
• 52-Week Range: $1.37 to $17.04
• Volume: 112,413 shs
• Average Volume: 1.30 million shs
• Market Capitalization: $3.07 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IVF Stock Analysis - Frequently Asked Questions

How have IVF shares performed this year?

INVO Fertility's stock was trading at $2.18 at the beginning of 2025. Since then, IVF stock has decreased by 34.9% and is now trading at $1.42.
View the best growth stocks for 2025 here.

How were INVO Fertility's earnings last quarter?

INVO Fertility, Inc (NASDAQ:IVF) posted its quarterly earnings data on Tuesday, May, 20th. The company reported ($12.53) earnings per share (EPS) for the quarter. The company earned $1.64 million during the quarter.

How do I buy shares of INVO Fertility?

Shares of IVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 5/20/2025
• Today: 6/10/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Manufacturing
• Industry: Surgical, Medical, And Dental Instruments And Supplies
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:IVF
• CIK: 1417926
• Web: N/A
• Phone: (978) 878-9505
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $6.59 million
• Price / Sales: 0.47
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 2,161,000
• Free Float: N/A
• Market Cap: $3.07 million
• Optionable: N/A
• Beta: 2.23